L829-0422 Screening compound: 2-{3-[3-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}pyridine

L829-0422 Screening compound: 2-{3-[3-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}pyridine
L829-0422 Screening compound: 2-{3-[3-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}pyridine alternative view

Chemical Structure Depiction of ChemDiv screening compound L829-0422
2-{3-[3-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}pyridine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L829-0422

Molecular Formula

C19H14N4OS (C19 H14 N4 OS)

Compound Name

2-{3-[3-(2-cyclopropyl-1,3-thiazol-4-yl)phenyl]-1,2,4-oxadiazol-5-yl}pyridine

IUPAC name

2-{3-[3-(2-cyclopropyl-13-thiazol-4-yl)phenyl]-124-oxadiazol-5-yl}pyridine

SMILES

C(C1)C1c1nc(-c2cc(-c3noc(-c4ncccc4)n3)ccc2)cs1

InChI

InChI=1S/C19H14N4OS/c1-2-9-20-15(6-1)18-22-17(23-24-18)14-5-3-4-13(10-14)16-11-25-19(21-16)12-7-8-12/h1-6,9-12H,7-8H2

InChI Key

VSNIEXRUIWNQGA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478736

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

346.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

4.800

Distribution Coefficient, logD

4.799

Water Solubility, LogSw

-4.99

Polar Surface Area

50.678

Acid Dissociation Constant (pKa)

23.73

Base Dissociation Constant (pKb)

4.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

15.80

L829-0422 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

GPCR Targeted Library (31838 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L829-0422 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L829-0422?
Check Price and Availability of L829-0422, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L829-0422 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L829-0422
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L829-0422
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L829-0422 available by request